Literature DB >> 19232820

Guggulsterone induces apoptosis in colon cancer cells and inhibits tumor growth in murine colorectal cancer xenografts.

Min Ji An1, Jae Hee Cheon, Seung Won Kim, Eun Soo Kim, Tae Il Kim, Won Ho Kim.   

Abstract

The plant sterol guggulsterone has recently been shown to have anti-tumorigenic potential. This study was designed to investigate the anti-tumor efficacy of guggulsterone and to elucidate its molecular mechanisms in colon cancer. Guggulsterone significantly increased apoptosis in HT-29 cells by activating caspases-3 and -8. Furthermore, guggulsterone decreased cIAP-1, cIAP-2, and Bcl-2 levels and increased the levels of truncated Bid, Fas, p-JNK, and p-c-Jun. The size of HT-29 xenograft tumors in guggulsterone-treated mice was significantly smaller than of the size of tumors in control mice. The present study suggests a potential therapeutic use for this compound in the treatment of colorectal cancer.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19232820     DOI: 10.1016/j.canlet.2009.01.026

Source DB:  PubMed          Journal:  Cancer Lett        ISSN: 0304-3835            Impact factor:   8.679


  21 in total

1.  Prevention of endotoxin-induced uveitis in rats by plant sterol guggulsterone.

Authors:  Nilesh M Kalariya; Mohammad Shoeb; Aramati B M Reddy; Min Zhang; Frederik J G M van Kuijk; Kota V Ramana
Journal:  Invest Ophthalmol Vis Sci       Date:  2010-04-30       Impact factor: 4.799

2.  Guggulsterone induces apoptosis of human hepatocellular carcinoma cells through intrinsic mitochondrial pathway.

Authors:  Juan-Juan Shi; Xiao-Li Jia; Mei Li; Ning Yang; Ya-Ping Li; Xin Zhang; Ning Gao; Shuang-Suo Dang
Journal:  World J Gastroenterol       Date:  2015-12-21       Impact factor: 5.742

Review 3.  Inhibitor of apoptosis protein family as diagnostic markers and therapeutic targets of colorectal cancer.

Authors:  Koh Miura; Wataru Fujibuchi; Kazuyuki Ishida; Takeshi Naitoh; Hitoshi Ogawa; Toshinori Ando; Nobuki Yazaki; Kazuhiro Watanabe; Sho Haneda; Chikashi Shibata; Iwao Sasaki
Journal:  Surg Today       Date:  2011-01-26       Impact factor: 2.549

4.  Guggulsterone inhibits human cholangiocarcinoma Sk-ChA-1 and Mz-ChA-1 cell growth by inducing caspase-dependent apoptosis and downregulation of survivin and Bcl-2 expression.

Authors:  Fei Zhong; Jing Yang; Zhu-Ting Tong; Liu-Liu Chen; Lu-Lu Fan; Fang Wang; Xia-Li Zha; Jun Li
Journal:  Oncol Lett       Date:  2015-06-19       Impact factor: 2.967

5.  Guggulsterone enhances antitumor activity of gemcitabine in gallbladder cancer cells through suppression of NF-κB.

Authors:  Moon Hee Yang; Kyu Taek Lee; Sera Yang; Jong Kyoon Lee; Kwang Hyuck Lee; Il Hwan Moon; Jong Chul Rhee
Journal:  J Cancer Res Clin Oncol       Date:  2012-06-15       Impact factor: 4.553

6.  Prevention and Treatment of Colorectal Cancer by Natural Agents From Mother Nature.

Authors:  Bharat Aggarwal; Sahdeo Prasad; Bokyung Sung; Sunil Krishnan; Sushovan Guha
Journal:  Curr Colorectal Cancer Rep       Date:  2013-03-01

7.  Guggulsterone decreases proliferation and metastatic behavior of pancreatic cancer cells by modulating JAK/STAT and Src/FAK signaling.

Authors:  Muzafar A Macha; Satyanarayana Rachagani; Suprit Gupta; Priya Pai; Moorthy P Ponnusamy; Surinder K Batra; Maneesh Jain
Journal:  Cancer Lett       Date:  2013-08-03       Impact factor: 8.679

8.  Guggulsterone targets smokeless tobacco induced PI3K/Akt pathway in head and neck cancer cells.

Authors:  Muzafar A Macha; Ajay Matta; Shyam Singh Chauhan; K W Michael Siu; Ranju Ralhan
Journal:  PLoS One       Date:  2011-02-24       Impact factor: 3.240

9.  14-3-3 zeta is a molecular target in guggulsterone induced apoptosis in head and neck cancer cells.

Authors:  Muzafar A Macha; Ajay Matta; Ss Chauhan; Kw Michael Siu; Ranju Ralhan
Journal:  BMC Cancer       Date:  2010-11-30       Impact factor: 4.430

10.  Src-mediated cross-talk between farnesoid X and epidermal growth factor receptors inhibits human intestinal cell proliferation and tumorigenesis.

Authors:  Zhongsheng Peng; Jean-Pierre Raufman; Guofeng Xie
Journal:  PLoS One       Date:  2012-10-31       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.